Stay Up to Date
Featured News
FDA APPROVES OGSIVEO™ (NIROGACESTAT), AS THE FIRST MEDICAL THERAPY FOR THE TREATMENT OF ADULTS WITH PROGRESSING DESMOID TUMORS.
Filter by:
Clinical Trials December 27, 2022
Breaking News: Springworks Therapeutics Announces Submission Of New Drug Application For Nirogacestat To The U.S. FDA
November 22, 2022
Desmoid Tumors In The Spotlight At The 2022 Connective Tissue Oncology Society (CTOS) Conference
October 27, 2022
DTRF And PeerView Offer CME Accredited Course At CTOS On Treatment Of Desmoid Tumors
Read More about DTRF And PeerView Offer CME Accredited Course At CTOS On Treatment Of Desmoid Tumors
October 20, 2022
DTRF Exec. Dir. Presents At CTOS Webinar On Desmoid Tumors, The CTOS 2022 “Sarcoma Of The Year”
Research 
September 30, 2022
Desmoid Tumor Awareness Month 2022 Comes To A Close
Read More about Desmoid Tumor Awareness Month 2022 Comes To A Close
September 27, 2022
DTRF Hosts Successful 2022 Virtual DTRF “Together We Will” Weekend
Read More about DTRF Hosts Successful 2022 Virtual DTRF “Together We Will” Weekend
Clinical Trials September 13, 2022
*Big News*: Exciting Results Announced For Two Promising Desmoid Tumor Clinical Trials At ESMO Conference In France
July 21, 2022
CTOS Names “Desmoid Fibromatosis” The 2022 “Sarcoma Of The Year” For Fall Conference
Read More about CTOS Names “Desmoid Fibromatosis” The 2022 “Sarcoma Of The Year” For Fall Conference
June 6, 2022
Registration Is Open For The 2022 Virtual DTRF “Together We Will” Weekend!
Read More about Registration Is Open For The 2022 Virtual DTRF “Together We Will” Weekend!
Clinical Trials May 25, 2022
Breaking News: Springworks Therapeutics Announces Topline Results From Phase 3 DeFi Trial
January 28, 2022
DTRF Launches Radiomics Working Group To Improve Tumor Measurement
Read More about DTRF Launches Radiomics Working Group To Improve Tumor Measurement
January 24, 2022
Special Announcement: DTRF Co-Founder Marlene Portnoy Transitions To Board Of Directors
November 19, 2021
DTRF Receives Global Genes Champions Of Hope “Rare Champion In Advocacy (Foundation)” Award
October 26, 2021
Breaking News: DTRF-Funded Research Results In Two Stable Desmoid Tumor Cell Lines
Read More about Breaking News: DTRF-Funded Research Results In Two Stable Desmoid Tumor Cell Lines
